CCM
BSX icon

Coerente Capital Management’s Boston Scientific BSX Stock Holding History

Coerente Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,265
Closed -$268K – 44
2026
Q1 		$268K Sell
4,265
-175
-4% -$14K 0.05% 42
2025
Q4 		$423K Buy
+4,440
New +$435K 0.08% 41

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
MF
Milford Funds Auckland $6.14B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return

Coerente Capital Management's BSX Position: Q2 2026 in Review

Coerente Capital Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,265 shares — an estimated $268K sold.

Coerente Capital Management first reported a position in BSX in Q4 2025 and held it in 2 quarters. The position peaked at $423K in Q4 2025. 536 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Coerente Capital Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Coerente Capital Management sold 4,265 Boston Scientific shares in Q2 2026, an estimated $268K.
  • Coerente Capital Management first reported a position in Boston Scientific in Q4 2025 and held it in 2 quarters.
  • Coerente Capital Management's Boston Scientific position peaked at $423K in Q4 2025.
  • 536 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Coerente Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.